Sarepta Therapeutics
SRPT
Rank 1962
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, US
Sarepta Therapeutics - Key figures
Market cap 5.77 Billion
Revenue 701.89 Million
Profit -165,844,000
P/E Ratio No information
P/s Ratio 8.22
Sarepta Therapeutics - Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases.
The company is headquartered in Cambridge, Massachusetts.